DNLI position history
The shares of Denali Therapeutics (DNLI) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q1: 127,900 shares, $1.7M, 0.49% of portfolio, New
- 2025 Q2: 168,500 shares, $2.4M, 0.65% of portfolio, Add +31.7%
- 2025 Q3: 168,500 shares, $2.4M, 0.60% of portfolio
- 2025 Q4: 318,500 shares, $5.3M, 1.2% of portfolio, Add +89.0%
- 2026 Q1: 318,500 shares, $6.1M, 1.4% of portfolio
- 2026 Q2: 739,014 shares, $19M, 3.6% of portfolio, Add +132.0%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|